Gov. Abigail Spanberger has approved up to $191 million in state grant money for AstraZeneca, which is building a $4.5 ...

AstraZeneca (AZN) is one of the biggest players in the healthcare sector, whose medicines save the lives of tens of thousands of people every year. In this article, I will share six reasons why I ...

ALBEMARLE COUNTY, Va. (WRIC) — AstraZeneca, a pharmaceutical company, has officially announced that its new drug substance manufacturing facility will come to Albemarle County, creating 600 direct ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter. It is a diversified fund that focuses on long-term capital appreciation by ...

The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.

Another phase 3 trial, Chestnut, evaluated children who switched from Strensiq to efzimfotase alfa. The study showed ...

AstraZeneca PLC is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. AZN's financials show improving margins, rising EPS, and ...

View AstraZeneca PLC AZN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Gov. Glenn Youngkin announced Thursday that global pharmaceutical manufacturer and biotech company AstraZeneca will invest $4.5 billion to establish two new manufacturing facilities in Albemarle ...

Shares of AstraZeneca PLC AZN slipped 1.59% to £149.88 Monday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.17% to 10,582.96.

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and President ...

LONDON (Reuters) - AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases. The spin-off of the three ...